EGFR Tyrosine Kinase Inhibitors
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EGFR Tyrosine Kinase Inhibitors, covering 2012-12-10 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations [Phase 3]